1. Home
  2. ATEC vs HRMY Comparison

ATEC vs HRMY Comparison

Compare ATEC & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alphatec Holdings Inc.

ATEC

Alphatec Holdings Inc.

HOLD

Current Price

$13.90

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$37.06

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATEC
HRMY
Founded
1990
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.1B
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
ATEC
HRMY
Price
$13.90
$37.06
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
8
Target Price
$22.36
$49.75
AVG Volume (30 Days)
4.2M
616.4K
Earning Date
02-24-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
50.44
EPS
N/A
3.17
Revenue
$728,020,000.00
$825,944,000.00
Revenue This Year
$27.10
$23.34
Revenue Next Year
$16.77
$16.28
P/E Ratio
N/A
$11.77
Revenue Growth
27.11
21.13
52 Week Low
$8.81
$25.52
52 Week High
$23.29
$40.87

Technical Indicators

Market Signals
Indicator
ATEC
HRMY
Relative Strength Index (RSI) 26.75 48.18
Support Level $13.43 $36.27
Resistance Level $15.55 $38.04
Average True Range (ATR) 0.70 1.18
MACD -0.15 -0.03
Stochastic Oscillator 6.91 50.14

Price Performance

Historical Comparison
ATEC
HRMY

About ATEC Alphatec Holdings Inc.

Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: